(Q45986186)

English

Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson's disease

scientific article published on June 6, 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson's disease (English)

1 reference

10.1016/S0006-8993(96)01192-4

https://api.crossref.org/works/10.1016/S0006-8993(96)01192-4

6 November 2024

Parkinson's disease

1 reference

based on heuristic

inferred from title

Anumantha G Kanthasamy

1

object named as

A G Kanthasamy

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

3

object named as

R R Matsumoto

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

4

object named as

T Q Vu

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

5

object named as

D D Truong

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

author name string

A. Kanthasamy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219856

6 November 2024

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

6 June 1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9219856

6 November 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0006899396011924?httpAccept=text/xml

1 reference

10.1016/S0006-8993(96)01192-4

https://api.crossref.org/works/10.1016/S0006-8993(96)01192-4

6 November 2024

https://api.elsevier.com/content/article/PII:S0006899396011924?httpAccept=text/plain

1 reference

10.1016/S0006-8993(96)01192-4

https://api.crossref.org/works/10.1016/S0006-8993(96)01192-4

6 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

759

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

1-8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

NMDA antagonists partially protect against MPTP induced neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glutamate neurotoxicity and diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Oxidative stress, glutamate, and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glutamate receptors in the substantia nigra of Parkinson's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

NMDA Receptor Activation Produces Concurrent Generation of Nitric Oxide and Reactive Oxygen Species: Implications for Cell Death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

7-Chlorokynurenate Blocks NMDA Receptor-Mediated Neurotoxicity in Murine Cortical Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Excitoprotective effect of felbamate in cultured cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Dopaminergic neurotoxicity of cyanide: neurochemical, histological, and behavioral characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The glycine site of the NMDA receptor--five years on.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

NMDA-dependent superoxide production and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Molecular cloning and characterization of the rat NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Effects of the enantiomers of (+/-)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Dopa and dopamine cause cultured neuronal death in the presence of iron

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Quisqualate- and NMDA-sensitive [3H]glutamate binding in primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901192-4

7 January 2021

Identifiers

10.1016/S0006-8993(96)01192-4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/9219856

Semantic Scholar paper ID

1ecf995f94c34b1f01196425ccf315464f388bf8

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45986186&oldid=2270830074"